Foundry Partners’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-333,843
Closed -$5.24M 295
2024
Q3
$5.24M Buy
+333,843
New +$5.06M 0.26% 121
2018
Q1
Sell
-348,874
Closed -$6.59M 410
2017
Q4
$6.59M Buy
348,874
+11,059
+3% +$245K 0.27% 132
2017
Q3
$9.86M Buy
337,815
+26,448
+8% +$781K 0.39% 88
2017
Q2
$10M Buy
311,367
+50,381
+19% +$1.65M 0.41% 86
2017
Q1
$9.03M Buy
260,986
+37,407
+17% +$1.34M 0.38% 88
2016
Q4
$7.89M Hold
223,579
0.34% 96
2016
Q3
$7.76M Buy
223,579
+9,210
+4% +$322K 0.41% 90
2016
Q2
$8.01M Buy
+214,369
New +$8.06M 0.45% 79

Other funds holding ACH

Foundry Partners's ACH Position: Q4 2024 in Review

Foundry Partners sold out of Accendra Health (ACH) in Q4 2024, closing a stake of 333,843 shares — an estimated $5.24M sold.

Foundry Partners first reported a position in ACH in Q2 2016 and held it in 8 quarters. The position peaked at $10M in Q2 2017. 198 funds tracked by Wall St. Rank hold ACH as of Q4 2024.

  • Foundry Partners reported no remaining Accendra Health position as of Q4 2024 after selling out during the quarter.
  • Foundry Partners sold 333,843 Accendra Health shares in Q4 2024, an estimated $5.24M.
  • Foundry Partners first reported a position in Accendra Health in Q2 2016 and held it in 8 quarters.
  • Foundry Partners's Accendra Health position peaked at $10M in Q2 2017.
  • 198 funds tracked by Wall St. Rank held Accendra Health as of Q4 2024.

Based on Foundry Partners's 13F filing for Q4 2024, filed 12 Feb 2025.